Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CDK2 INHIBITORS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/039903
Kind Code:
A3
Abstract:
The present invention provides bicyclic and monocyclic heterocyclic amine compounds, with sulfoxide, sulfone or sulfonamide functionality, useful as inhibitors of cyclin-dependent kinase 2 (CDK2), as well as inhibitors of CDK2 and cyclin E1 (CCNE1) protein. Further disclosed are compositions thereof, and methods of using the same for treating a variety of diseases, disorders or conditions, associated with regulation of CDK2 protein, including, but not limited to, cancers that are characterized by amplification or overexpression of CCNEI.

Inventors:
COLLIER PHILIP (US)
ZHENG XIAOZHANG (US)
ZHU XIAO (US)
FORD MELISSA (US)
WEISS MATTHEW (US)
AVERSA ROBERT (US)
MAHASENAN KIRAN VIJAYAKUMARI (US)
ZHANG YI (US)
Application Number:
PCT/US2023/030721
Publication Date:
April 18, 2024
Filing Date:
August 21, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYMERA THERAPEUTICS INC (US)
International Classes:
C07D471/04; A61K31/519; A61K31/545; C07D401/14; C07D487/04
Foreign References:
US20210107901A12021-04-15
US20200399273A12020-12-24
US20200392142A12020-12-17
Attorney, Agent or Firm:
REID, Andrea, L.C. et al. (US)
Download PDF: